Journal
ANTIVIRAL RESEARCH
Volume 138, Issue -, Pages 1-8Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2016.11.021
Keywords
African swine fever; Pigs; Immunisation routes; Protection; Cytokines
Categories
Funding
- BBSRC [BB/L004267/1]
- Biotechnology and Biological Sciences Research Council [BBS/E/I/00002014, BBS/E/I/00001709, BB/L004267/1] Funding Source: researchfish
- BBSRC [BBS/E/I/00001709, BB/L004267/1, BBS/E/I/00002014] Funding Source: UKRI
Ask authors/readers for more resources
This study compares different combinations of doses and routes of immunisation of pigs with low virulent African swine fever virus (ASFV) genotype I isolate OURT88/3, including the intramuscular and intranasal route, the latter not previously tested. Intranasal immunisations with low and moderate doses (10(3) and 10(4) TCID50) of OURT88/3 provided complete protection (100%) against challenge with virulent genotype I OURT88/1 isolate. Only mild and transient clinical reactions were observed in protected pigs. Transient moderate virus genome levels were detected in blood samples after challenge that decreased, but persisted until the end of the experiment in some animals. In contrast, pigs immunised intramuscularly with low and moderate doses (10(3) and 10(4) TCID50) displayed lower percentages of protection (50-66%), and low or undetectable levels of virus genome were detected in blood samples throughout the study. In addition, clinical courses observed in protected pigs were asymptomatic. In pigs that were not protected and developed acute ASF, an exacerbated increase of IL-10 sometimes accompanied by an increase of IFN gamma was observed before euthanasia. These results showed that factors including delivery route and dose determine the outcome of immunisation with the naturally attenuated isolate OURT88/3. (C) 2016 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available